Publication

Therapeutic antibodies targeting app-c99

Related publications (33)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Therapeutic antibodies targeting app-c99

Graph Chatbot

Chat with Graph Search

Half a century of amyloids: past, present and future

Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives

Application of anti-amyloid beta immunization using encapsulated cell technology in mouse models of Alzheimer's disease

The metalloprotease ADAMTS4 generates N-truncated A4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease

Effect of the Synaptic Plasma Membrane on the Stability of the Amyloid Precursor Protein Homodimer

A subcutaneous cellular implant for passive immunization against amyloid-beta reduces brain amyloid and tau pathologies

Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint

Structural differences of amyloid-beta fibrils revealed by antibodies from phage display

The adipocyte differentiation protein APMAP is an endogenous suppressor of Aβ production in the brain

New Insights Into Amyloid Formation and Structure by Innovative Atomic Force Microscopy Methods